SCHEMBL342236

SCHEMBL342236

CCNC(=O)N[C@@H](CS)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.61
KDM4E B2RXH2 1/20 0.61
THRB P10828 1/20 0.61
ALOX15 P16050 1/20 0.61
NFKB1 P19838 1/20 0.61
PTGS2 P35354 1/20 0.61
THPO P40225 1/20 0.61
RECQL P46063 1/20 0.61
BLM P54132 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
FOLH1 Q04609 4/20 0.56
ACE P12821 1/20 0.55
NAALAD2 Q9Y3Q0 3/20 0.44
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
KMT2A Q03164 1/20 0.41
RIMKLA Q8IXN7 1/20 0.41
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7256391 1.00 MAPT (0.61) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL7253429 1.00 MAPT (0.61) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL31490542 0.83 SMN1; SMN2 (0.53) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL21844360 0.83 MAPT (0.50) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL5317744 0.81 MAPT (0.63) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL31690474 0.81 TGFBR1 (0.52) MAPTFOLH1NAALAD2MEN1ALDH1A1
SCHEMBL11017381 0.81 MAPT (0.63) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL1158100 0.80
SCHEMBL499352 0.80
SCHEMBL340834 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2450194-B1 Recording medium CANON KK (JP) 2015-06-17 EP disclosed
US-8722159-B2 Recording medium CANON KABUSHIKI KAISHA (JP) 2014-05-13 US disclosed
EP-1874948-B1 Process for the production of y-glutamylcysteine NEWSOUTH INNOVATIONS PTY LTD (AU) 2013-03-20 EP disclosed
US-8236533-B2 Process for the production of γ-glutamylcysteine NEWSOUTH INNOVATIONS PTY LIMITED (AU) 2012-08-07 US disclosed
EP-2450194-A2 Recording medium Canon Kabushiki Kaisha (JP) 2012-05-09 EP disclosed
US-20120015119-A1 RECORDING MEDIUM CANON KABUSHIKI KAISHA (JP) 2012-01-19 US disclosed
US-20090136993-A1 Process for the Production of Gamma-Glutamylcysteine NEWSOUTH INNOVATIONS PTY LIMITED 2009-05-28 US disclosed
EP-1874948-A1 PROCESS FOR THE PRODUCTION OF y-GLUTAMYLCYSTEINE Newsouth Innovations Pty Limited (AU) 2008-01-09 EP disclosed
WO-2006102722-A1 PROCESS FOR THE PRODUCTION OF Ϝ-GLUTAMYLCYSTEINE NEWSOUTH INNOVATIONS PTY LIMITED (AU) 2006-10-05 WO disclosed
US-20030215788-A1 Cysteine thiol-protected peptides for use in immunoassays BLAKE JAMES (US) 2003-11-20 US disclosed
WO-1990015071-A1 CYSTEINE THIOL-PROTECTED PEPTIDES FOR USE IN IMMUNOASSAYS GENETIC SYSTEMS CORPORATION (US) 1990-12-13 WO disclosed
EP-0139005-A1 ANTITUMOR COMPOSITION, METHOD FOR TREATING TUMOR, AND USE OF THE COMPOSITION FOR TREATING TUMOR Yoshitomi Pharmaceutical Industries, Ltd. (JP) 1985-05-02 EP disclosed
US-4228077-A N-[2-(mercaptoalkyl)-3-mercaptoalkanoyl]-l-tryptophanes E. R. SQUIBB & SONS, INC. (US) 1980-10-14 US disclosed
US-4206121-A ANGIOTENSIN, ENZYME INHIBITORS E. R. SQUIBB & SONS, INC. (US) 1980-06-03 US disclosed
US-4178291-A HYPOTENSIVE AGENTS, ENZYME INHIBITORS E. R. SQUIBB & SONS, INC. (US) 1979-12-11 US disclosed
US-4176235-A ANGIOTENSIN COVERTING ENZYME INHIBITORS E. R. SQUIBB & SONS, INC. (US) 1979-11-27 US disclosed
US-4175199-A Substituted acyl derivatives of amino acids E. R. SQUIBB & SONS, INC. (US) 1979-11-20 US disclosed
US-4154936-A ENZYME INHIBITORS, HYPOTENSIVE E. R. SQUIBB & SONS, INC. (US) 1979-05-15 US disclosed
US-4140864-A ANGIOTENSIN CONVERTING ENZYME INHIBITORS E. R. SQUIBB & SONS, INC. (US) 1979-02-20 US disclosed
US-4116962-A ANGIOTENSIN CONVERTING ENXYME INHIBITORS E. R. SQUIBB & SONS, INC. (US) 1978-09-26 US disclosed